Susquehanna lowered the firm’s price target on NOV Inc. (NOV) to $21 from $22 and keeps a Positive rating on the shares. The firm updated its model following Q3 earnings noting the biggest uncertainty around growth in 2025 is North America, which has been a challenging environment in 2024. That said, they expect the company to outpace broader market activity levels next year while continuing to grow margins.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
- NOV Inc. sees 2024 adjusted EBITDA at lower end of previous $1.10B-$1.18B view
- NOV Inc. reports Q3 EPS 33c, consensus 36c
- NOV Inc. sees Q4 revenue growth down 3%-5% vs. last year, consensus $2.36B
- National Oilwell options imply 4.3% move in share price post-earnings
- NOV Inc. (NOV) Q3 Earnings Cheat Sheet